Severe eosinophilic asthma — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Severe eosinophilic asthma
The recurrent exacerbations despite optimised high-dose inhaled therapy, high FeNO and marked eosinophilia indicate severe eosinophilic asthma. Omalizumab-type allergic asthma is less likely because IgE and skin prick testing are not supportive, and vocal cord dysfunction would not explain the type 2 inflammatory markers. ABPA would need Aspergillus sensitisation or central bronchiectasis, while COPD is not the best fit in this phenotype.
Reference: BTS/NICE/SIGN Asthma Guideline NG245; NICE severe asthma technology appraisals